From: The need for post-operative vasopressor infusions after major gynae-oncologic surgery within an ERAS (Enhanced Recovery After Surgery) pathway
CRP (mg/l)
Sensitivity
Specificity
≥ 80
0.6
0.7
≥ 100
0.4
0.8